20 December 2017
Washington DC
Reporter: Barney Dixon

PTAB institutes IPR against Lantus patents

The US Patent Trial and Appeal Board (PTAB) has instituted inter partes review (IPR) against patents for Sanofi’s Lantus insulin glargine injection.

In October, Sanofi initiated a patent infringement lawsuit against Mylan’s new drug application for a generic version of Lantus. Mylan responded by challenging Sanofi’s patents at the PTAB in an IPR.

Lantus is a prescription medicine for improving glycemic control in adult patients with diabetes.

Heather Bresch, CEO of Mylan, commented: “The PTAB's decision to institute IPR proceedings against the two Orange Book-listed patents for Lantus is another step forward in our ongoing efforts to bring an interchangeable insulin glargine to diabetes patients as soon as possible.”

She said: “There are more than 29 million people in the US living with diabetes who deserve access to more affordable treatment options. As a leading producer of oral diabetes medicines, we are deeply committed to this patient community and believe bringing lower-cost alternatives to Lantus and Lantus SoloSTAR will fulfill a critical medical need."

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
Nokia in deep waters at USITC
22 January 2018 | Washington DC | Reporter: Barney Dixon
The USITC will investigate Nokia over alleged infringement of Neptune Subsea Acquisitions and Xtera’s subsea telecommunication systems patents
Google and Tencent sign patent agreement
22 January 2018 | Shenzhen | Reporter: Barney Dixon
Google and Tencent have signed a long-term patent cross-licensing agreement, covering a range of products and technologies
Qualcomm NXP merger approved
19 January 2018 | Brussels | Reporter: Barney Dixon
The European Commission has approved Qualcomm’s acquisition of NXP, subject to full compliance with a series of commitments made by Qualcomm
Brinks, Gilson & Lione elects new president
19 January 2018 | Chicago | Reporter: Barney Dixon
Brinks, Gilson & Lione has elected a new president to succeed James Sobieraj
G&E launches IP practice
18 January 2018 | Wilmington | Reporter: Barney Dixon
Grant & Eisenhofer has launched an intellectual property practice, led by patent-trade secrets trial lawyer, Eric Evain
SCOTUS to hear extraterritorial damages question
17 January 2018 | Washington DC | Reporter: Barney Dixon
The US Supreme Court is to hear a case that considers whether patent owners should be able to recover lost profits from infringement outside of the US
Microsoft expands IP protection to Azure Stack
16 January 2018 | Redmond | Reporter: Barney Dixon
Microsoft has expanded its Azure intellectual property risk protection programme to cover its Azure Stack hybrid cloud platform